Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Costus extract refers to botanical preparations derived from plants of the genus *Costus* (such as *Costus speciosus*) or the species *Saussurea costus*. These extracts are widely used in traditional medicine for their anti-inflammatory, anti-microbial, and anti-diabetic properties. In oncological research, methanolic extracts of Costus have been investigated for their ability to inhibit the viability of various cancer cell lines, including lung, colon, breast, and cervical cancers. The therapeutic potential of the extract is largely attributed to bioactive phytochemicals such as sesquiterpene lactones (e.g., costunolide and dehydrocostus lactone), which are known to induce apoptosis and modulate pro-survival signaling pathways. While primarily categorized as a dietary supplement or nutraceutical, it remains a subject of preclinical study for potential therapeutic applications in cancer and metabolic diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Costus extract.